军事知识服务平台
环泊酚与5种质子泵抑制剂模拟Y管给药配伍的稳定性
Compatibility and Stability of Ciprofol with Five Proton Pump Inhibitors in Simulated Y-site Administration
摘要 目的 考察 5 种质子泵抑制剂(PPIs)注射液和环泊酚注射液模拟 Y 管给药的配伍稳定性,为重症监护室用药提供参考依据.方法 在室温(25±1)℃下,模拟临床用浓度,将5 种PPIs 注射液(奥美拉唑钠、艾司奥美拉唑钠、泮托拉唑钠、兰索拉唑及雷贝拉唑钠)与环泊酚注射液按体积比 1∶1 配伍混合,于 0、2、4、6、8 h测定 pH 值、药物含量、粒径、多分散指数(PDI)、Zeta 电位(ZP)、渗透压并观察外观及显微形态.结果 5 种配伍液外观均无变化,pH 值波动范围在±5%内,平均粒径约200 nm,PDI 值<0.2,Zeta 电位>20 mV,渗透压摩尔浓度 291~296 mOsm·kg-1,显微显示乳滴未出现聚集和变大.在4h时间点雷贝拉唑钠与环泊酚配伍液中雷贝拉唑钠的相对百分含量下降至91.0%,其他配伍液的药物含量均保持在95.0%~105.0%.结论 在室温条件下,奥美拉唑钠、艾司奥美拉唑钠、泮托拉唑钠、兰索拉唑与环泊酚配伍液在8h内理化性质均保持稳定.雷贝拉唑钠、环泊酚配伍液中雷贝拉唑钠含量随时间变化逐渐下降,需现配现用以保证用药安全有效.
Abstract:
Objective To evaluate the compatibility and stability of five proton pump inhibitors(PPIS)injections when co-administered with ciprofol injection under simulated Y-site conditions,thereby providing evidence-based guidance for clinical use in intensive care units.Methods Five PPIs(omeprazole sodium,esomeprazole sodium,pantoprazole sodium,lansoprazole,and rabeprazole sodium)injections were mixed with ciprofol injection at a 1∶1(V/V)ratio under room tempera-ture(25±1)℃to replicate clinically relevant concentrations.The mixtures were evaluated at 0,2,4,6,and 8 hours for the fol-lowing parameters:pH value,drug content,particle size,polydispersity index(PDI),zeta potential,osmolality,as well as vis-ual appearance and microscopic morphology.Results All five compatibility solutions maintained unchanged appearance with pH variations within±5%.The formulations showed mean particle sizes around 200 nm,polydispersity index(PDI)<0.2,Zeta potential above 20 mV,and osmolality from 291 to 296 mOsm·kg-1.Microscopic examination revealed no droplet aggregation or size increase.At the 4-hour timepoint,rabeprazole sodium content in the ciprofol combination dropped 91.0%,while other com-binations maintained drug contents within 95.0%-105.0%.Conclusions Under simulated Y-site conditions at room tempera-ture,omeprazole sodium,esomeprazole sodium,pantoprazole sodium,and lansoprazole demonstrated both physical and chemical stability when combined with ciprofol for up to 8 h.However,the rabeprazole sodium-ciprofol mixture exhibited gradual drug deg-radation and should be administered immediately after preparation to ensure efficacy and safety.
刊 名 医药导报 ISTICPKU
年,卷(期): 2026, 45(10)
分类号: R975.6 R971.2 R969.2
机标分类号: R917 R573.1 O656.3
在线出版日期: 2026年11月2日
基金项目: 25Y147:十堰市科学技术局资助项目,